Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin

Srinivas Mutalik, Neelam A. Suthar, Renuka S. Managuli, Pallavi K. Shetty, Kiran Avadhani, Guruprasad Kalthur, Raghavendra V. Kulkarni, Ranjeny Thomas

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Inflammatory bowel disease (IBD) is an inflammatory condition with mucosal ulceration, edema and hemorrhage of gastrointestinal tract. Curcumin has been shown to mitigate colitis in animal models. However, its usefulness is reduced due to poor pharmacokinetic behavior and low oral bioavailability. To address this, novel pH-sensitive hydrolyzed polyacrylamide-grafted-xanthan gum (PAAm-g-XG) nanoparticles (NPs) loaded with curcumin were prepared for colonic delivery. Optimized nanoparticles (CN20) were spherical, with an average size of 425 nm. A negligible amount of curcumin (≈8%) was released from CN20 NPs in pH 1.2 and 4.5 solutions. When the pH was increased to 7.2, curcumin release was comparatively faster than that observed with pH 1.2 and 4.5 collectively. In pH 6.8 solution, excellent release of curcumin was observed. Highest curcumin release was observed when rat caecal contents were incorporated in pH 6.8 solution, indicating microflora-dependent drug release property of NPs. In acetic acid-induced IBD in rats, curcumin NPs reduced myeloperoxidase and nitrite levels, prevented weight loss and attenuated colonic inflammation. Curcumin was better absorbed systemically in nanoparticulate form with increased Cmax (~3 fold) and AUC (~2.5 fold) than when delivered as free curcumin. We demonstrate successful development of grafted co-polymeric NPs containing drug suitable for colon targeting.

Original languageEnglish
Pages (from-to)709-720
Number of pages12
JournalInternational Journal of Biological Macromolecules
Volume86
DOIs
Publication statusPublished - 01-05-2016

Fingerprint

Curcumin
Nanoparticles
Copolymers
Inflammatory Bowel Diseases
Rats
Pharmacokinetics
Colitis
Nitrites
Acetic Acid
Pharmaceutical Preparations
Peroxidase
Biological Availability
Area Under Curve
Gastrointestinal Tract
Weight Loss
Edema
Colon
Animals
Animal Models
Hemorrhage

All Science Journal Classification (ASJC) codes

  • Structural Biology
  • Biochemistry
  • Molecular Biology

Cite this

Mutalik, Srinivas ; Suthar, Neelam A. ; Managuli, Renuka S. ; Shetty, Pallavi K. ; Avadhani, Kiran ; Kalthur, Guruprasad ; Kulkarni, Raghavendra V. ; Thomas, Ranjeny. / Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin. In: International Journal of Biological Macromolecules. 2016 ; Vol. 86. pp. 709-720.
@article{4960ae253aa54c5cacb7b3bdbdbcff16,
title = "Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin",
abstract = "Inflammatory bowel disease (IBD) is an inflammatory condition with mucosal ulceration, edema and hemorrhage of gastrointestinal tract. Curcumin has been shown to mitigate colitis in animal models. However, its usefulness is reduced due to poor pharmacokinetic behavior and low oral bioavailability. To address this, novel pH-sensitive hydrolyzed polyacrylamide-grafted-xanthan gum (PAAm-g-XG) nanoparticles (NPs) loaded with curcumin were prepared for colonic delivery. Optimized nanoparticles (CN20) were spherical, with an average size of 425 nm. A negligible amount of curcumin (≈8{\%}) was released from CN20 NPs in pH 1.2 and 4.5 solutions. When the pH was increased to 7.2, curcumin release was comparatively faster than that observed with pH 1.2 and 4.5 collectively. In pH 6.8 solution, excellent release of curcumin was observed. Highest curcumin release was observed when rat caecal contents were incorporated in pH 6.8 solution, indicating microflora-dependent drug release property of NPs. In acetic acid-induced IBD in rats, curcumin NPs reduced myeloperoxidase and nitrite levels, prevented weight loss and attenuated colonic inflammation. Curcumin was better absorbed systemically in nanoparticulate form with increased Cmax (~3 fold) and AUC (~2.5 fold) than when delivered as free curcumin. We demonstrate successful development of grafted co-polymeric NPs containing drug suitable for colon targeting.",
author = "Srinivas Mutalik and Suthar, {Neelam A.} and Managuli, {Renuka S.} and Shetty, {Pallavi K.} and Kiran Avadhani and Guruprasad Kalthur and Kulkarni, {Raghavendra V.} and Ranjeny Thomas",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ijbiomac.2015.11.092",
language = "English",
volume = "86",
pages = "709--720",
journal = "International Journal of Biological Macromolecules",
issn = "0141-8130",
publisher = "Elsevier",

}

Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin. / Mutalik, Srinivas; Suthar, Neelam A.; Managuli, Renuka S.; Shetty, Pallavi K.; Avadhani, Kiran; Kalthur, Guruprasad; Kulkarni, Raghavendra V.; Thomas, Ranjeny.

In: International Journal of Biological Macromolecules, Vol. 86, 01.05.2016, p. 709-720.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin

AU - Mutalik, Srinivas

AU - Suthar, Neelam A.

AU - Managuli, Renuka S.

AU - Shetty, Pallavi K.

AU - Avadhani, Kiran

AU - Kalthur, Guruprasad

AU - Kulkarni, Raghavendra V.

AU - Thomas, Ranjeny

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Inflammatory bowel disease (IBD) is an inflammatory condition with mucosal ulceration, edema and hemorrhage of gastrointestinal tract. Curcumin has been shown to mitigate colitis in animal models. However, its usefulness is reduced due to poor pharmacokinetic behavior and low oral bioavailability. To address this, novel pH-sensitive hydrolyzed polyacrylamide-grafted-xanthan gum (PAAm-g-XG) nanoparticles (NPs) loaded with curcumin were prepared for colonic delivery. Optimized nanoparticles (CN20) were spherical, with an average size of 425 nm. A negligible amount of curcumin (≈8%) was released from CN20 NPs in pH 1.2 and 4.5 solutions. When the pH was increased to 7.2, curcumin release was comparatively faster than that observed with pH 1.2 and 4.5 collectively. In pH 6.8 solution, excellent release of curcumin was observed. Highest curcumin release was observed when rat caecal contents were incorporated in pH 6.8 solution, indicating microflora-dependent drug release property of NPs. In acetic acid-induced IBD in rats, curcumin NPs reduced myeloperoxidase and nitrite levels, prevented weight loss and attenuated colonic inflammation. Curcumin was better absorbed systemically in nanoparticulate form with increased Cmax (~3 fold) and AUC (~2.5 fold) than when delivered as free curcumin. We demonstrate successful development of grafted co-polymeric NPs containing drug suitable for colon targeting.

AB - Inflammatory bowel disease (IBD) is an inflammatory condition with mucosal ulceration, edema and hemorrhage of gastrointestinal tract. Curcumin has been shown to mitigate colitis in animal models. However, its usefulness is reduced due to poor pharmacokinetic behavior and low oral bioavailability. To address this, novel pH-sensitive hydrolyzed polyacrylamide-grafted-xanthan gum (PAAm-g-XG) nanoparticles (NPs) loaded with curcumin were prepared for colonic delivery. Optimized nanoparticles (CN20) were spherical, with an average size of 425 nm. A negligible amount of curcumin (≈8%) was released from CN20 NPs in pH 1.2 and 4.5 solutions. When the pH was increased to 7.2, curcumin release was comparatively faster than that observed with pH 1.2 and 4.5 collectively. In pH 6.8 solution, excellent release of curcumin was observed. Highest curcumin release was observed when rat caecal contents were incorporated in pH 6.8 solution, indicating microflora-dependent drug release property of NPs. In acetic acid-induced IBD in rats, curcumin NPs reduced myeloperoxidase and nitrite levels, prevented weight loss and attenuated colonic inflammation. Curcumin was better absorbed systemically in nanoparticulate form with increased Cmax (~3 fold) and AUC (~2.5 fold) than when delivered as free curcumin. We demonstrate successful development of grafted co-polymeric NPs containing drug suitable for colon targeting.

UR - http://www.scopus.com/inward/record.url?scp=84957812893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957812893&partnerID=8YFLogxK

U2 - 10.1016/j.ijbiomac.2015.11.092

DO - 10.1016/j.ijbiomac.2015.11.092

M3 - Article

VL - 86

SP - 709

EP - 720

JO - International Journal of Biological Macromolecules

JF - International Journal of Biological Macromolecules

SN - 0141-8130

ER -